One-Year Longitudinal Changes in Tau Accumulation on [18F]PI-2620 PET in the Alzheimer Spectrum

Conclusion: These findings suggest that [18F]PI-2620 PET can be a biomarker to provide regional and chronologic information about tau pathology in the AD continuum.

Source: Journal of Nuclear Medicine - March 1, 2024 Category: Nuclear Medicine Authors: Oh, M., Oh, S. J., Lee, S. J., Oh, J. S., Seo, S. Y., Ryu, S., Roh, J. H., Lee, J.-H., Kim, J. S. Tags: Clinical Investigations Source Type: research